Clinical Trials Browser

Phase 2 × Perivascular Epithelioid Cell Neoplasms × pembrolizumab × Clear all

NCT07089992 2025-12-16

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Phase 2 Recruiting

Liposarcoma, Sarcoma, Perivascular Epithelioid Cell Neoplasms